共 50 条
Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis Arthritis
被引:26
|作者:
Clements, Philip J.
[1
]
Allanore, Yannick
[2
]
Khanna, Dinesh
[3
]
Singh, Minjit
[4
]
Furst, Daniel E.
[1
]
机构:
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Paris Descartes Univ, Cochin Hosp, APHP, Rheumatol Dept A, Paris, France
[3] Univ Michigan, Scleroderma Program, Ann Arbor, MI 48109 USA
[4] Rochester Gen Hlth Syst, Rochester, NY USA
关键词:
systemic sclerosis;
scleroderma;
arthritis in systemic sclerosis;
musculoskeletal involvement in systemic sclerosis;
quality of life;
function;
HEALTH-ASSESSMENT QUESTIONNAIRE;
CYCLIC CITRULLINATED PEPTIDE;
HAND FUNCTION;
JOINT INVOLVEMENT;
DEMONSTRATE CHANGE;
DOUBLE-BLIND;
VALIDITY;
RELIABILITY;
DISABILITY;
DISEASE;
D O I:
10.1016/j.semarthrit.2011.10.003
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objectives: Musculoskeletal (MSK) pain is a frequent (between 40-80%) complaint of patients with systemic sclerosis (SSc). Unfortunately, there are virtually no systematic studies of the causes or the management of MSK involvement in SSc and with few exceptions there have been no controlled trials to determine what are and should be the best strategies for managing MSK pain and synovitis in patients with SSc. Methods: A literature search was conducted for published reports that have addressed the clinical assessment of "arthritis" and "musculoskeletal" involvement in SSc. The literature search was a prelude to developing recommendations/suggestions for performing clinical trials (preferably randomized) in the future in SSc-related arthritis. Results: The search netted a number of articles that reported clinical assessments of arthritis in SSc, but very few reported results of controlled clinical trials. Nevertheless, a prevalence of clinical arthritis and tools used to assess the involvement (clinical examination, functional assessments and assessments of quality of life, and radiographic imaging) was found. Conclusions: Most of the tools used to assess arthritis in SSc patients have not been validated and additional work is needed to develop a "core set" of variables for assessment of arthritis in SSc and its response to treatment. This report furnishes the background information that can help provide the building blocks for the development of a "core set" that can be used to chart the efficacy of new treatments for SSc-related arthritis in the future. (C) 2012 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 41:801-814
引用
收藏
页码:801 / 814
页数:14
相关论文